Tin tức & Cập nhật

Adults who develop ocular motor cranial neuropathy (OMCN), particularly at a younger age, are at greater risk of having dementia, reveals a study.

A combination of the TKI* cabozantinib and ICI** atezolizumab improved progression-free survival (PFS) in men with metastatic castration-resistant prostate cancer (mCRPC) with measurable extrapelvic nodal or visceral metastasis who progressed on prior novel hormonal therapy (NHT), findings from the phase III CONTACT-02 trial have shown.